Wide Ranks

MURA

Mural Oncology plc

4.04

Top Statistics
Market Cap 68 M Forward PE -0.8565 Revenue Growth 0.00 %
Current Ratio 8.65 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA 0.7970 Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 204 M Total Cash Per Share 12.02 Total Debt 11 M
Total Debt To Equity 5.42 Current Ratio 8.65 Book Value Per Share 15.81
All Measures
Short Ratio 385.00 % Message Board Id finmb_1835230342 Shares Short Prior Month 465839
Return On Equity -1.78 City Dublin Uuid 56213005-23be-395c-8a2a-a8485dd4c587
Previous Close 3.93 First Trade Date Epoch Utc 1 B Book Value 15.81
Total Debt 11 M Volume 327303 Price To Book 0.2556
Fifty Two Week Low 2.88 Total Cash Per Share 12.02 Shares Short Previous Month Date 1 B
Target Median Price 18.00 Max Age 86400 Sand P52 Week Change 0.3133
Target Mean Price 16.33 Net Income To Common -173296992 Short Percent Of Float 0.0242
Implied Shares Outstanding 17 M Trailing Peg Ratio None Last Fiscal Year End 1 B
Average Daily Volume10 Day 346200 Average Volume10days 346200 Total Cash 204 M
Next Fiscal Year End 1 B Held Percent Insiders 0.0115 Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 3.93
Target Low Price 13.00 Gmt Off Set Milliseconds -18000000 Fifty Day Average 3.45
Open 4.02 Free Cashflow -92149376 Dividend Yield 0.00 %
Return On Assets -0.8105 Time Zone Short Name EST Trailing Eps -9.02
Day Low 3.90 Address1 10 Earlsfort Terrace Shares Outstanding 17 M
Price Hint 4 Target High Price 18.00 Website https://www.muraloncology.com
52 Week Change 0.1191 Average Volume 127439 Forward Eps -5.07
Recommendation Key none Compensation As Of Epoch Date 1 B Quick Ratio 837.90 %
Is_sp_500 False Regular Market Day High 4.10 Profit Margins 0.00 %
Debt To Equity 5.42 Fifty Two Week High 6.25 Day High 4.10
Shares Short 412862 Regular Market Open 4.02 Industry Key biotechnology
Earnings Growth 0.00 % Revenue Growth 0.00 % Shares Percent Shares Out 0.0242
Operating Cashflow -159892992 Currency USD Time Zone Full Name America/New_York
Market Cap 68 M Is_nasdaq_100 False Zip D02 T380
Quote Type EQUITY Industry Biotechnology Long Name Mural Oncology plc
Regular Market Day Low 3.90 Held Percent Institutions 0.6943 Current Price 4.04
Enterprise To Ebitda 0.7970 Financial Currency USD Current Ratio 8.65
Industry Disp Biotechnology Number Of Analyst Opinions 3 Country Ireland
Float Shares 13 M Two Hundred Day Average 3.70 Enterprise Value -134161408
Forward PE -0.8565 Regular Market Volume 327303 Ebitda -168398000
Exchange NGM
Go to Yahoo Finance Go to Seeking Alpha 
Mural Oncology plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer.

The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab.

It also develops nemvaleukin to treat cutaneous melanoma and advanced solid tumors.

The company is also developing engineered interleukin-18 and tumor-targeted interleukin-12 programs.

Mural Oncology plc was incorporated in 2017 and is based in Dublin, Ireland.